Order Article Reprints

Pielenhofer J, Meiser SL, Gogoll K, Ciciliani A-M, Denny M, Klak M, Lang BM, Staubach P, Grabbe S, Schild H, et al. Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product. Pharmaceutics. 2023; 15(2):514. https://doi.org/10.3390/pharmaceutics15020514

Pielenhofer, Jonas, Sophie Luise Meiser, Karsten Gogoll, Anna-Maria Ciciliani, Mark Denny, Michael Klak, Berenice M. Lang, Petra Staubach, Stephan Grabbe, Hansjörg Schild, and et al. 2023. "Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product" Pharmaceutics 15, no. 2: 514. https://doi.org/10.3390/pharmaceutics15020514

Pielenhofer, J., Meiser, S. L., Gogoll, K., Ciciliani, A. -M., Denny, M., Klak, M., Lang, B. M., Staubach, P., Grabbe, S., Schild, H., Radsak, M. P., Spahn-Langguth, H., & Langguth, P. (2023). Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product. Pharmaceutics, 15(2), 514. https://doi.org/10.3390/pharmaceutics15020514